Affordable Access

Publisher Website

Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.

Authors
Journal
FEMS Yeast Research
1567-1356
Publisher
Oxford University Press
Publication Date
Volume
9
Issue
7
Identifiers
DOI: 10.1111/j.1567-1364.2009.00578.x
Keywords
  • Regulation
  • Antifungal Agents
  • Resistance
  • Genome-Wide Expression
  • Candida-Albicans Biofilms
  • Amino-Acid Substitutions
  • Mdr1 Efflux Pump
  • Reduced Echinocandin Susceptibility
  • Increased Fluconazole Resistance
  • Major Facilitator Superfamily
  • Human-Immunodeficiency-Virus
  • Sterol 14-Demethylase P450
  • Transporter-Encoding Gene
Disciplines
  • Medicine

Abstract

Fungi are primitive eukaryotes and have adapted to a variety of niches during evolution. Some fungal species may interact with other life forms (plants, insects, mammals), but are considered as pathogens when they cause mild to severe diseases. Chemical control strategies have emerged with the development of several drugs with antifungal activity against pathogenic fungi. Antifungal agents have demonstrated their efficacy by improving patient health in medicine. However, fungi have counteracted antifungal agents in several cases by developing resistance mechanisms. These mechanisms rely on drug resistance genes including multidrug transporters and drug targets. Their regulation is crucial for the development of antifungal drug resistance and therefore transcriptional factors critical for their regulation are being characterized. Recent genome-wide studies have revealed complex regulatory circuits involving these genetic and transcriptional regulators. Here, we review the current understanding of the transcriptional regulation of drug resistance genes from several fungal pathogens including Candida and Aspergillus species.

There are no comments yet on this publication. Be the first to share your thoughts.